Psytech-logo-tovana3

Enabling safe, personalized, protocol-driven, AND data-rich Psychedelic Assisted Therapy

Objectives of Tovana:

Tovana provides therapists and patients the most data-rich information, simply presented, to track and adapt progress for psychedelic- assisted therapy, in order to achieve:

    • Deeper insight and more efficiency for the therapist
    • Deeper insight and better outcomes for the patient 
    • Deeper insight through groundbreaking data for the researcher

How we Achieve These Objectives:

Tovana achieves these objectives with 3 primary tools:

Therapist Dashboard:

This includes features such as questionnaire selection, biometric data parameters, intervention triggers, and reports for both therapist and patient which can be personalized with ease from the therapist dashboard.

 

Patient App:

Passive and prompted data collection is transformed into insights, alerts, and interventions for both the patient and the therapist.

Patient Wearable:

Passive biometric data flows from the wearable to Tovana, where it gets transformed into actionable information.

 

 

 

 

 

Patient Wearable:

Passive biometric data flows from the wearable to Tovana, where it gets transformed into actionable information.

This includes features such as questionnaire selection, biometric data parameters, intervention triggers, and reports for both therapist and patient which can be personalized with ease from the therapist dashboard.

Passive and prompted data collection is transformed into insights, alerts, and interventions for both the patient and the therapist.

Passive biometric data flows from the wearable to Tovana, where it gets transformed into actionable information.

How Tovana’s Data Driven Insights Are Applied in All Phases of Psychedelic-Assisted Therapy

Phase 1: Safety screening & protocol personalization 

➔ Ensures patient safety through quality-assured screening.

➔ Promotes best practices through programmable protocols adapting to individual patient.

➔ Sets individualized baseline from real-world biometric data capture (HR, HRV, Sleep, Geofencing, and more).

Phase 2: Therapy Set and Setting

➔ Ensures patient safety through heart rate monitoring.

➔ Promotes protocol adherence in integration therapy through adaptive survey guidance.

➔ Qualitative and quantitative patient data delivered on Tovana’s comprehensive dashboard.

Phase 3: Integration & Monitoring 

➔ Using Tovana, patient’s therapy is more effective due to better adherence to protocol.

➔ Doctor is enabled with more actionable data, in real time, to treat patients more effectively. 

Phase 4: Use in perpetuity

➔ Patient moves to post-protocol self monitoring and continues to use wearable and app to help with monitoring and integration.

➔ Doctor moves to post protocol emergency support and receives both active alerts and passive alerts from the patient’s Tovana app.

Framing The need

MENTAL HEALTH 1 out of 5, or nearly 70 million Americans are affected each year by mental disorders; mostly anxiety, mood, and substance use disorders. This number has been increasing, costs more than  heart disease by a factor of 8, and constitutes an epidemic.

DIGITAL HEALTH

Results shows that digital mental health increases data volume, engagement, adherence to protocol, and improves therapeutic outcomes. 

PSYCHEDELIC MEDICINE 63% of Americans report be open to medical treatment with psilocybin, ketamine, or MDMA. FDA awarded “Breakthrough” status to MDMA and Psilocybin therapies for mental disorders. 

ILUMIVU, POWERING TOVANA

Tovana has adapted ilumivu for psychedelic therapy, exclusively.  ilumivu has been developing its mEMA platform for 10 years and has been selected, proven and improved through rigorous use in some of the best institutions in the world, studying mental health issues such as suicidal ideation and substance abuse.

 

management team

Hayim Raclaw, BA, CBA

Chief Executive Officer

Cory Jones, MA

Chief Marketing Officer

Yaron Eshel, BSc, MBA

Director,

Life Sciences & Co-Founder

Mark Goldhar, 

BCom, CPA CA 

Chief Financial Officer

Advisory team

Dr. Abid Nazeer, MD

Kat Houghton, PhD

Dr. Robin Ely, MD

Shlomit Dekel, BA, MBA

Contact us for more information

Check Out Our Upcoming Webinar!